Raffles Medical Group Ltd provides integrated private healthcare services primarily in Singapore, Greater China, Vietnam, Cambodia, and Japan. The company operates through Healthcare Services, Hospital Services, and Investment Holdings segments. Its flagship hospital is the Raffles Hospital, a tertiary care hospital that offers cancer, children and women care, Chinese medicine, counselling, dental, dialysis, diabetes and endocrinology, ear, nose, throat, eye, fertility, heart, internal medicine, neuroscience, pain management, rehabilitation, orthopedic, skin and aesthetics, surgery, nuclear medicine, and urology services. The company also offers emergency services, family medicine services, health screening, and various multi-disciplinary specialist clinic services. In addition, it trades in pharmaceutical and nutraceutical products, and diagnostic equipment; provides advisory and consultancy services, and develops IT solutions; and engages in research and experimental development on biotechnology, and life and medical science. Raffles Medical Group Ltd was founded in 1976 and is based in Singapore. Raffles Medical Group Ltd operates as a subsidiary of Raffles Medical Holdings Pte. Ltd.
General Outlook
In simple terms, Raffles Medical Group Ltd has 1861.475 M shares that people are buying and selling right now.
Stock Prices
Raffles Medical Group Ltd's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $0.8, while its low point bottomed out at $0.8. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Raffles Medical Group Ltd's stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”